Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

29.05.18	Juries Weigh Cases Over Alleged Harms Of Johnson & Johnson Baby Powder (RTTNews)
08.05.18	It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug. (RTTNews)
05.05.18	New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression (PR Newswire)
03.05.18	Johnson & Johnson to Participate in the 2018 UBS Global Health Care Conference (PR Newswire)
02.05.18	Johnson & Johnson to Host Consumer and Medical Devices Business Review (PR Newswire)
30.04.18	Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918 (RTTNews)
28.04.18	Biotech Stocks Facing FDA Decision In May (RTTNews)
26.04.18	Johnson & Johnson Announces Dividend Increase of 7.1% (PR Newswire)
24.04.18	Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference (PR Newswire)
24.04.18	Unison Reports Fast Company Growth Supported by Strategic Hires and New Market Expansion (PR Newswire)
18.04.18	FreeBackgroundCheck.org Announces Members Area Upgrades (PR Newswire)
17.04.18	Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions (RTTNews)
17.04.18	Johnson & Johnson Q1 adjusted earnings Beat Estimates (RTTNews)
17.04.18	Johnson & Johnson Reports 2018 First-Quarter Results: (PR Newswire)
11.04.18	FDA Approves First Contact Lens With Light-adaptive Technology (RTTNews)
10.04.18	Horizon Technology Finance Announces Renewal of Credit Facility (PR Newswire)
06.04.18	J&J, Imerys Ordered To Pay $37 Mln In Case Over Talc Cancer Risks (RTTNews)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
20.03.18	Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson (PR Newswire)
20.03.18	Johnson & Johnson to Host Investor Conference Call on First-Quarter Results (PR Newswire)
19.03.18	Syracuse Creative Agency Expands into Southern Tier (PR Newswire)
16.03.18	Johnson & Johnson gibt verbindliches Angebot von Platinum Equity zur Übernahme von LifeScan, Inc. bekannt (PR Newswire)
16.03.18	J&J Gets Binding Offer From Platinum Equity To Buy LifeScan Unit For $2.1 Bln (RTTNews)
16.03.18	Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc. (PR Newswire)
16.03.18	Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc. (PR Newswire)
16.03.18	Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc. (PR Newswire)
16.03.18	Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc. (PR Newswire)
13.03.18	Lifshitz & Miller LLP Announces Investigation of 8point3 Energy Partners LP, Grandpoint Capital, Inc., Hardinge Inc., Johnson & Johnson, LJM Funds Management Ltd., Nationstar Mortgage Holdings Inc. (PR Newswire)
08.03.18	Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials (PR Newswire)
06.03.18	Johnson & Johnson to Participate in Barclays Global Healthcare Conference (PR Newswire)
05.03.18	New Drugs Approved In February (RTTNews)
23.02.18	Milliman: Public pension funding improves by $60 billion, funded ratio climbs to 73.1% in 2017 Q4 (PR Newswire)
20.02.18	Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference (PR Newswire)
20.02.18	J&J Reportedly Explores Sale Of $2 Bln Sterilization Division (RTTNews)
16.02.18	Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting (PR Newswire)
09.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018 (PR Newswire)
09.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018 (PR Newswire)
09.02.18	FDA Nod For JNJ, CORI Awaits Results In Q2, MDGL's HeFH Data Fails To Impress (RTTNews)
08.02.18	Johnson & Johnson to Participate in the 2018 CAGNY Conference (PR Newswire)
08.02.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Johnson & Johnson (JNJ) (PR Newswire)
08.02.18	Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio (PR Newswire)
07.02.18	Johnson & Johnson to Participate in RBC Capital Markets 2018 Global Healthcare Conference (PR Newswire)
01.02.18	MeiraGTx Receives Rare Pediatric Disease Designation for A002 for the Treatment of Achromatopsia Due to Mutations in the CNGB3 Gene (PR Newswire)
31.01.18	Johnson & Johnson to Participate in the Leerink Partners 7th Annual Global Healthcare Conference (PR Newswire)
25.01.18	Bayer Shares the Risk with Cotton Farmers (PR Newswire)
23.01.18	Forty of the Nation's Most Promising Young Scientists Named Finalists in Regeneron Science Talent Search 2018 (PR Newswire)
23.01.18	Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View (RTTNews)
23.01.18	Johnson & Johnson Q4 Earnings Rise 10% (RTTNews)
23.01.18	Johnson & Johnson Reports 2017 Fourth-Quarter Results: (PR Newswire)
23.01.18	Earnings In Focus: Jan. 23 (FUL, ATI, JNJ, PG, VZ) (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

12.05.25		Ausblick: Bayer präsentiert Bilanzzahlen zum jüngsten Jahresviertel
12.05.25		Roche-Aktie legt zu: Roche investiert Milliardenbetrag in zwei US-Produktionstandorte
12.05.25		Bayer-Aktie fester: Bayer gibt Frankfurter Standort auf
12.05.25		Fresenius Medical Care (FMC) St-Analyse: DZ BANK verleiht Fresenius Medical Care (FMC) St-Aktie Kaufen in jüngster Analyse
12.05.25		Merck-Analyse: So bewertet Barclays Capital die Merck-Aktie
12.05.25		DAX 40-Wert Beiersdorf-Aktie: So viel Gewinn hätte ein Investment in Beiersdorf von vor 10 Jahren abgeworfen
12.05.25		DAX 40-Wert Merck-Aktie: So viel Verlust hätte eine Investition in Merck von vor 3 Jahren bedeutet
12.05.25		DAX 40-Papier Fresenius Medical Care (FMC) St-Aktie: So viel Gewinn hätte eine Investition in Fresenius Medical Care (FMC) St von vor einem Jahr abgeworfen

12.05.25

Ausblick: Bayer präsentiert Bilanzzahlen zum jüngsten Jahresviertel

12.05.25

Roche-Aktie legt zu: Roche investiert Milliardenbetrag in zwei US-Produktionstandorte

12.05.25

Bayer-Aktie fester: Bayer gibt Frankfurter Standort auf

12.05.25

Fresenius Medical Care (FMC) St-Analyse: DZ BANK verleiht Fresenius Medical Care (FMC) St-Aktie Kaufen in jüngster Analyse

12.05.25

Merck-Analyse: So bewertet Barclays Capital die Merck-Aktie

12.05.25

DAX 40-Wert Beiersdorf-Aktie: So viel Gewinn hätte ein Investment in Beiersdorf von vor 10 Jahren abgeworfen

12.05.25

DAX 40-Wert Merck-Aktie: So viel Verlust hätte eine Investition in Merck von vor 3 Jahren bedeutet

12.05.25

DAX 40-Papier Fresenius Medical Care (FMC) St-Aktie: So viel Gewinn hätte eine Investition in Fresenius Medical Care (FMC) St von vor einem Jahr abgeworfen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	72.20	8.15 %	K V
CieFinRichemont	154.40	6.45 %	K V
Part Grp Hldg	1’177.00	5.66 %	K V
UBS Group	27.11	4.43 %	K V
Kuehne+Nagel Int	185.15	4.10 %	K V
Swiss Life Hldg	829.40	-1.36 %	K V
Lonza Grp	575.80	-1.54 %	K V
Geberit	577.60	-1.60 %	K V
Nestle	86.21	-1.64 %	K V
Swisscom	532.00	-2.21 %	K V

Johnson & Johnson Aktie VALOR 943981 / ISIN US4781601046

Nachrichten zu Johnson & Johnson

Aktien Top/Flop

Johnson & Johnson Peer Group Nachrichten

Meistgelesene Nachrichten